Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Ivanes

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Cardiovascular Drugs and Therapy|July 1, 2010
Cardioprotection in the clinical settingFabrice Ivanes, Nathan Mewton, Gilles Rioufol, et al.
Stroke|May 28, 2016
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?Laurent Fauchier, Nicolas Clementy, Arnaud Bisson, et al.
Journal of Molecular and Cellular Cardiology|July 23, 2018
Stimulation of P2Y11 receptor modulates cardiac fibroblasts secretome toward immunomodulatory and protective roles after Hypoxia/Reoxygenation injuryClaudie Lefort, Lauriane Benoist, Stéphanie Chadet, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 4, 2016
Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort studyLaurent Fauchier, Nicolas Clementy, Arnaud Bisson, et al.
Scientific Reports|September 8, 2017
Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modellingDavid Ternant, Fabrice Ivanes, Fabrice Prunier, et al.
Archives of Cardiovascular Diseases|December 3, 2014
Ischaemic postconditioning reduces infarct size: systematic review and meta-analysis of randomized controlled trialsCaroline Touboul, Denis Angoulvant, Nathan Mewton, et al.
Chest|October 2, 2015
Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation ProjectLaurent Fauchier, Coralie Lecoq, Nicolas Clementy, et al.
Chest|March 27, 2015
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation ProjectDenis Angoulvant, Olivier Villejoubert, Theodora Bejan-Angoulvant, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 30, 2025
P2 purinergic receptors at the heart of pathological left ventricular remodeling following acute myocardial infarctionAna Valéria Vinhais da Silva, Simon Chesseron, Oumnia Benouna, et al.
International Journal of Cardiology|December 2, 2015
Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?Yann Ancedy, Coralie Lecoq, Christophe Saint Etienne, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Cardiovascular Drugs and Therapy|July 1, 2010
Cardioprotection in the clinical settingFabrice Ivanes, Nathan Mewton, Gilles Rioufol, et al.
Stroke|May 28, 2016
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?Laurent Fauchier, Nicolas Clementy, Arnaud Bisson, et al.
Journal of Molecular and Cellular Cardiology|July 23, 2018
Stimulation of P2Y11 receptor modulates cardiac fibroblasts secretome toward immunomodulatory and protective roles after Hypoxia/Reoxygenation injuryClaudie Lefort, Lauriane Benoist, Stéphanie Chadet, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 4, 2016
Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort studyLaurent Fauchier, Nicolas Clementy, Arnaud Bisson, et al.
Scientific Reports|September 8, 2017
Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modellingDavid Ternant, Fabrice Ivanes, Fabrice Prunier, et al.
Archives of Cardiovascular Diseases|December 3, 2014
Ischaemic postconditioning reduces infarct size: systematic review and meta-analysis of randomized controlled trialsCaroline Touboul, Denis Angoulvant, Nathan Mewton, et al.
Chest|October 2, 2015
Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation ProjectLaurent Fauchier, Coralie Lecoq, Nicolas Clementy, et al.
Chest|March 27, 2015
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation ProjectDenis Angoulvant, Olivier Villejoubert, Theodora Bejan-Angoulvant, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 30, 2025
P2 purinergic receptors at the heart of pathological left ventricular remodeling following acute myocardial infarctionAna Valéria Vinhais da Silva, Simon Chesseron, Oumnia Benouna, et al.
International Journal of Cardiology|December 2, 2015
Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?Yann Ancedy, Coralie Lecoq, Christophe Saint Etienne, et al.
Pageof 6